Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 11/07/2025 | PUT | $867.50 | 2,353 | +2,311 | +5,502.38% |
| 11/07/2025 | PUT | $865.00 | 2,364 | +2,266 | +2,312.24% |
| 01/22/2026 | CALL | $900.02 | 2,200 | +2,200 | |
| 01/22/2026 | PUT | $900.02 | 2,200 | +2,200 | |
| 11/14/2025 | CALL | $850.00 | 1,000 | +1,000 | |
| 11/14/2025 | PUT | $850.00 | 1,000 | +1,000 | |
| 11/07/2025 | CALL | $900.00 | 806 | -282 | -25.92% |
| 12/19/2025 | PUT | $780.00 | 839 | -330 | -28.23% |
| 11/21/2025 | PUT | $825.00 | 1,697 | -403 | -19.19% |
| 11/21/2025 | PUT | $850.00 | 762 | -591 | -43.68% |
| 11/21/2025 | CALL | $1,000.00 | 8,284 | -642 | -7.19% |
| 11/21/2025 | PUT | $800.00 | 1,439 | -1,224 | -45.96% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.74% | 26M | 11.45B |
| Vanguard 500 Index Fund | 1.92% | 18.23M | 8.03B |
| Vanguard/Primecap Fund | 1.56% | 14.85M | 6.54B |
| Fidelity 500 Index Fund | 0.91% | 8.65M | 3.81B |
| SPDR S&P 500 ETF Trust | 0.90% | 8.54M | 3.76B |
| Vanguard Specialized-Health Care Fund | 0.80% | 7.64M | 3.37B |
| iShares Core S&P 500 ETF | 0.74% | 7.04M | 3.1B |
| Washington Mutual Investors Fund | 0.73% | 6.95M | 3.06B |
| Growth Fund Of America Inc | 0.71% | 6.7M | 2.95B |
| Select Sector SPDR Fund-Health Care | 0.67% | 6.41M | 2.82B |
2 Reasons I'm Keeping My Eye on Eli Lilly Stock Right Now
11/05 07:09 pm
The Motley Fool
Read moreStocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday?
11/05 02:23 pm
Benzinga
Read moreEli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play
11/05 08:14 am
Investing.com
Read moreBillionaire Stanley Druckenmiller Dropped Nvidia and Palantir Stock and Is Piling into 2 Stocks Set to Win in One of the Decade's Hottest Growth Markets.
11/04 09:10 pm
The Motley Fool
Read moreGene Editing Market Size to Surpass USD 42.13 Billion by 2034
11/04 04:35 am
GlobeNewswire Inc.
Read moreWhat's Up With The Rise In Eli Lilly Stock Today?
11/03 02:54 pm
Benzinga
Read more2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon
11/03 09:28 am
The Motley Fool
Read moreShould You Buy Viking Therapeutics Before Nov. 5?
11/02 10:20 am
The Motley Fool
Read moreEli Lilly Seen In 'Pole Position' For Growth, Analysts Say
10/31 02:46 pm
Benzinga
Read moreMounjaro And Zepbound Power Eli Lilly's 54% Revenue Jump In Q3, Hikes 2025 Forecast
10/30 10:05 am
Benzinga
Read moreEli Lilly Outlook Brightens With FDA Wins and Global Expansion in Manufacturing
10/30 09:33 am
Investing.com
Read moreEli Lilly Advances AI And Access: Supercomputer With NVIDIA, Zepbound Via Walmart
10/29 02:26 pm
Benzinga
Read more1 Undervalued Growth Stock Down 8% to Buy Before 2026
10/28 08:10 pm
The Motley Fool
Read moreKen Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety
10/28 01:11 pm
Benzinga
Read moreWhat Is 1 of the Best Pharmaceutical Stocks to Buy Now?
10/27 12:21 pm
The Motley Fool
Read moreViking Therapeutics: High Risk, High Reward Play
10/27 11:12 am
Investing.com
Read moreShould You Buy Eli Lilly Stock Before Oct. 30?
10/27 07:31 am
The Motley Fool
Read moreBioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher?
10/26 06:33 pm
The Motley Fool
Read moreEli Lilly Bets Big On Eye Gene Therapy That Could End Repeat Injections
10/24 11:14 am
Benzinga
Read more2 Things Investors Should Know About Eli Lilly's $5 Billion Investment to Improve Its Drug Production Capacity
10/24 05:15 am
The Motley Fool
Read moreEccogene Eyes Hong Kong IPO With Experimental Weight-Loss Drug, AstraZeneca Partnership
10/23 09:22 am
Benzinga
Read moreHormone Replacement Therapy Market Poised to Reach USD 46.32 Billion by 2034, Growing at 6.68% CAGR: Towards Healthcare Report
10/23 09:00 am
GlobeNewswire Inc.
Read moreBig Money Exits: Iconic Pharma Stock Sold by High-Profile Asset Manager
10/22 08:36 am
The Motley Fool
Read moreWeight Loss Drugs Market Set to Reach USD 50.26 Billion by 2032, Driven by Prescription Drug Adoption and Breakthrough Formulations – SNS Insider
10/20 09:00 am
GlobeNewswire Inc.
Read moreInvestment Advisor Goes All-In on Big Pharma Stock to the Tune of $1.07 Billion, According to Recent Filing
10/19 07:01 pm
The Motley Fool
Read moreLarge Wealth Advisor Trims Exposure to Red-Hot Digital Advertising Stock
10/19 05:33 pm
The Motley Fool
Read moreGot $5,000? 2 Stocks to Buy Now and Hold for the Long Term
10/19 11:10 am
The Motley Fool
Read moreNovo Nordisk Stock Seen Undervalued Despite Pullback and 2026 Growth Focus
10/16 11:13 am
Investing.com
Read moreEli Lilly's Oral Weight Loss Drug Shows Superiority Over Two Approved Drugs
10/15 01:24 pm
Benzinga
Read moreNew to Investing? These Are 3 Solid Blue Chip Stocks You Can Build Your Portfolio Around
10/15 03:30 am
The Motley Fool
Read more1 Reason Eli Lilly (LLY) Is One of the Best Healthcare Stocks You Can Buy Today
10/14 08:05 pm
The Motley Fool
Read moreDown 44%, Should You Buy the Dip on Viking Therapeutics?
10/13 10:15 am
The Motley Fool
Read moreThe Smartest Growth Stock to Buy With $100 Right Now
10/13 07:23 am
The Motley Fool
Read moreDrug Stocks Just Had Their Best Week in 2 Decades. Should You Invest?
10/13 06:10 am
The Motley Fool
Read moreMolecule Therapeutics Market Size, Companies and Emerging Technologies Insight – Towards Healthcare
10/10 09:00 am
GlobeNewswire Inc.
Read moreHere's How This Pharmaceutical Giant Is Protecting Itself From President Trump's Tariffs. Should It Matter to Investors?
10/10 03:18 am
The Motley Fool
Read moreWatch Out Eli Lilly, This Pharma Giant Is Gunning to Be a Top Player in the Obesity Market
10/09 07:30 am
The Motley Fool
Read moreTencent- and Meituan-Backed Chinese Obesity Drug Maker Sciwind Eyes Hong Kong IPO
10/09 07:18 am
Benzinga
Read moreThese 2 AI Stocks Could Surpass Oracle in Market Cap by 2030
10/08 06:31 am
The Motley Fool
Read moreWegovy, Ozempic Maker Novo Nordisk Cuts Staff At Key US Production Sites
10/07 01:57 pm
Benzinga
Read moreLong-Term Study Shows Sustained Remission With Eli Lilly's Ulcerative Colitis Drug
10/07 11:05 am
Benzinga
Read moreEli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
10/07 04:26 am
Investing.com
Read more4BIO Capital founded Trogenix secures £70 million Series A financing to drive clinical development of potentially curative therapies for aggressive cancers
10/06 02:05 am
GlobeNewswire Inc.
Read more2 Beaten-Down Stocks Primed for a Comeback
10/05 02:30 pm
The Motley Fool
Read moreCRISPR Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight
10/02 01:00 pm
GlobeNewswire Inc.
Read more6 Healthcare Stocks Positioned to Soar After Trump-Pfizer Deal
10/02 12:15 pm
Investing.com
Read more3 Blue Chip Stocks That Have Soared 380% (and Higher) Over the Past 5 Years
10/02 05:27 am
The Motley Fool
Read more